Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Equity Average (2016 - 2025)

Historic Equity Average for Sanara MedTech (SMTI) over the last 13 years, with Q3 2025 value amounting to $20.8 million.

  • Sanara MedTech's Equity Average fell 4901.43% to $20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.8 million, marking a year-over-year decrease of 4901.43%. This contributed to the annual value of $42.0 million for FY2024, which is 268.39% down from last year.
  • According to the latest figures from Q3 2025, Sanara MedTech's Equity Average is $20.8 million, which was down 4901.43% from $36.0 million recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Equity Average registered a high of $44.3 million during Q4 2023, and its lowest value of $20.8 million during Q3 2025.
  • Its 5-year average for Equity Average is $36.9 million, with a median of $39.6 million in 2024.
  • Per our database at Business Quant, Sanara MedTech's Equity Average surged by 51745.43% in 2021 and then tumbled by 4901.43% in 2025.
  • Sanara MedTech's Equity Average (Quarter) stood at $32.3 million in 2021, then soared by 35.07% to $43.6 million in 2022, then grew by 1.73% to $44.3 million in 2023, then fell by 10.71% to $39.6 million in 2024, then crashed by 47.53% to $20.8 million in 2025.
  • Its Equity Average stands at $20.8 million for Q3 2025, versus $36.0 million for Q2 2025 and $38.0 million for Q1 2025.